fda decision: cytisinicline by achieve life sciences (on 2026-01-01)
Conditional / Accelerated Approval
fda decision: cytisinicline by achieve life sciences (on 2026-01-01). Best Yes near 9¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 9¢ · Best No: 94¢ · 1 platform
- Kalshi: Yes 9¢ / No 94¢
LIVE
Conditional / Accelerated Approval
Volume
$544
$15 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jul 1, 2026
~15 days left
Category
Economics
Yes
9¢
Kalshi
No
94¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA's decision on Cytisinicline by Achieve Life Sciences in June 2026 is Conditional / Accelerated Approval before Jul 1, 2026, the market resolves to Yes.
Market Details
ResolutionResolves Jul 1, 2026
Time Left15 days
Status● Active
CategoryEconomics
Yes
9¢
Kalshi
Payout 11.1x
No
94¢
Kalshi
Payout 1.1x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In